Zacks Investment Research downgraded shares of MEAD JOHNSON NU (MJN) from NEUTRAL to UNDERPERFORM on November 21, 2012, with a target price of $64.10.
Mead Johnson, a global leader in pediatric nutrition, develops, manufactures, markets and distributes more than 70 products in over 50 markets worldwide. The company's mission is to nourish the world’s children for the best start in life. The Mead Johnson name has been associated with science-based pediatric nutrition products for over 100 years. The company’s "Enfa" family of brands, including Enfamil infant formula, is the world's leading brand franchise in pediatric nutrition.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on MEAD JOHNSON NU (MJN),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment